SBSB
ABBV icon

Sullivan, Bruyette, Speros & Blaney’s AbbVie ABBV Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$2.36M Buy
21,833
+2,555
+13% +$273K 0.1% 58
2020
Q4 		$2.07M Buy
19,278
+2,612
+16% +$251K 0.1% 61
2020
Q3 		$1.46M Buy
16,666
+744
+5% +$70K 0.08% 77
2020
Q2 		$1.56M Sell
15,922
-152
-0.9% -$13.4K 0.09% 64
2020
Q1 		$1.23M Buy
16,074
+534
+3% +$45.5K 0.09% 72
2019
Q4 		$1.38M Sell
15,540
-2,063
-12% -$171K 0.08% 75
2019
Q3 		$1.33M Buy
17,603
+473
+3% +$32.4K 0.08% 68
2019
Q2 		$1.25M Buy
17,130
+159
+0.9% +$12.5K 0.08% 69
2019
Q1 		$1.37M Sell
16,971
-9
-0.1% -$736 0.08% 65
2018
Q4 		$1.56M Buy
16,980
+1,110
+7% +$97.6K 0.11% 46
2018
Q3 		$1.5M Buy
15,870
+190
+1% +$18K 0.14% 37
2018
Q2 		$1.45M Buy
15,680
+4
+0% +$391 0.14% 37
2018
Q1 		$1.48M Sell
15,676
-53
-0.3% -$5.82K 0.14% 37
2017
Q4 		$1.52M Sell
15,729
-71
-0.4% -$6.69K 0.14% 40
2017
Q3 		$1.4M Buy
15,800
+749
+5% +$57K 0.14% 39
2017
Q2 		$1.09M Buy
15,051
+424
+3% +$28.5K 0.11% 52
2017
Q1 		$953K Sell
14,627
-799
-5% -$50.2K 0.09% 51
2016
Q4 		$966K Sell
15,426
-168
-1% -$10.3K 0.1% 47
2016
Q3 		$984K Buy
15,594
+1,106
+8% +$71.6K 0.1% 46
2016
Q2 		$897K Buy
+14,488
New +$883K 0.09% 50

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's ABBV Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney increased its AbbVie (ABBV) stake by 13% in Q1 2021, buying an estimated $273K and bringing the position to 21,833 shares worth $2.36M. The position accounts for 0.1% of the portfolio, ranked #58.

Sullivan, Bruyette, Speros & Blaney first reported a position in ABBV in Q2 2016 and has held it in 20 quarters since. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 21,833 shares of AbbVie worth $2.36M as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney bought 2,555 AbbVie shares in Q1 2021, an estimated $273K.
  • AbbVie made up 0.1% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #58 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in AbbVie in Q2 2016 and has held it in 20 quarters since.
  • 2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.